These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 34631695)

  • 1. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
    Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
    Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model.
    Cao H; Huang P; Qiu J; Gong X; Cao H
    Heliyon; 2024 Feb; 10(3):e24861. PubMed ID: 38317886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis.
    Huang C; Zhang C; Sheng J; Wang D; Zhao Y; Qian L; Xie L; Meng Z
    Front Genet; 2021; 12():717319. PubMed ID: 34899826
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma.
    Shen B; Zhang G; Liu Y; Wang J; Jiang J
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma.
    Xi D; Wang J; Yang Y; Ji F; Li C; Yan X
    BMC Med Genomics; 2023 Sep; 16(1):211. PubMed ID: 37674210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Bioinformatic Analysis Reveals an Autophagy-related Gene Signature for Predicting Outcome, Immune Status, and Drug Sensitivity in Hepatocellular Carcinoma.
    Liu P; Zhou Y; Zeng S; Chen X
    Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38204266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
    Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
    Front Surg; 2022; 9():836080. PubMed ID: 35392063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a Novel Endoplasmic Reticulum-Related Prognostic Model for Hepatocellular Carcinomas.
    Ding F; Li J; Zhang Y; Wang C; Yu Y
    Oxid Med Cell Longev; 2022; 2022():8248355. PubMed ID: 35915607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing an immune-related prognostic signature for predicting prognosis and immune response in hepatocellular carcinoma.
    Cao L; Huang D; Zhang S; Li Z; Cai Q; Chen F; Zhu M; Ba Y; Chen J; Zhang H
    Heliyon; 2024 Jul; 10(13):e34012. PubMed ID: 39071637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.
    Zhang D; Liu S; Wu Q; Ma Y; Zhou S; Liu Z; Sun W; Lu Z
    Front Med (Lausanne); 2023; 10():1232814. PubMed ID: 37502362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
    Ouyang G; Yi B; Pan G; Chen X
    Cancer Cell Int; 2020; 20():207. PubMed ID: 32514252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
    Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
    Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.
    Xie F; Bai Y; Yang X; Long J; Mao J; Lin J; Wang D; Song Y; Xun Z; Huang H; Yang X; Zhang L; Mao Y; Sang X; Zhao H
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107135. PubMed ID: 33189609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 19. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
    Bi Y; Jing Y; Guo L
    Front Genet; 2022; 13():1017551. PubMed ID: 36263426
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.
    Zhu Z; Song M; Li W; Li M; Chen S; Chen B
    Front Oncol; 2021; 11():695001. PubMed ID: 34616672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.